Phreesia, Inc. (LON:0A23)
London flag London · Delayed Price · Currency is GBP · Price in USD
28.50
-0.54 (-1.86%)
At close: Jan 31, 2025

Phreesia Revenue

Phreesia had revenue of $115.94M USD in the quarter ending April 30, 2025, with 14.54% growth. This brings the company's revenue in the last twelve months to $434.53M, up 16.29% year-over-year. In the fiscal year ending January 31, 2025, Phreesia had annual revenue of $419.81M with 17.83% growth.

Revenue (ttm)
$434.53M
Revenue Growth
+16.29%
P/S Ratio
3.49
Revenue / Employee
$208.71K
Employees
2,082
Market Cap
1.14B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Jan 31, 2025419.81M63.51M17.83%
Jan 31, 2024356.30M75.39M26.84%
Jan 31, 2023280.91M67.68M31.74%
Jan 31, 2022213.23M64.56M43.42%
Jan 31, 2021148.68M23.89M19.15%
Jan 31, 2020 Pro Pro Pro
Jan 31, 2019 Pro Pro Pro
Jan 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.53B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Genus 671.60M
Revenue Rankings